MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Cognitive strategy use during daily activities in people with Parkinson’s Disease

    I. Sturkenboom, E. Steultjens, M. Nott, C. Chapparo (Nijmegen, Netherlands)

    Objective: To identify difficulties in cognitive strategy use observed in people with Parkinsons’s disease (PD) during performance of everyday activities. Background: People use cognitive strategies…
  • 2017 International Congress

    Understanding the role of LRRK2 in Indian population

    A. Kishore, M. Sturm, A. Sreelatha, S. Robert, S. Krishnan, M. Banerjee, O. Riess, P. Bauer, R. Kruger, T. Gasser, M. Sharma (Trivandrum, India)

    Objective: Genomic approaches  in Caucasian population show little transferability to other ethnically diverse populations such as Indian population. Understanding the genetic architecture of a disease…
  • 2017 International Congress

    Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease

    A. Ivashynka, S. Likhachev (Minsk, Belarus)

    Objective: Genetic testing Parkin (PARK 2) gene in patients with young-onset Parkinson's disease in Belarus. Background: The diagnosis of young-onset Parkinson's disease (PD) is the same…
  • 2017 International Congress

    Are there genotype-phenotype correlations in Perrys syndrome?

    J. Panicker, M. Bonello, R. Ellis, A. Randall, L. Fratalia, S. Alusi (Liverpool, United Kingdom)

    Objective: To examine  genotype-phenotype correlations in a cohort of three patients with Perrys syndrome.  Background: Perrys syndrome is a rare cause of familial parkinsonism. Since the…
  • 2017 International Congress

    Changes in motor subtype designation of early Parkinson’s disease patients

    R. Eisinger, D. Martinez-Ramirez, C. Hess, M. Okun, A. Gunduz (Gainesville, FL, USA)

    Objective: To examine changes in the designation of motor subtypes in Parkinson's disease (PD) patients within five years of diagnosis. Background: Distinct motor subtypes of…
  • 2017 International Congress

    Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

    C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)

    Objective: To correlate Parkinson's disease (PD) subtypes with a clinical severity in a Brazilian population sample. Background: Current studies have shown that PD may comprise…
  • 2017 International Congress

    Baseline predictors for clinical progression after 48 month follow-up in early Parkinson’s disease from the DeNoPa cohort

    B. Mollenhauer, J. Zimmermann, F. Sixel-Döring, N. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, C. Trenkwalder (Kassel, Germany)

    Objective: To analyze clinical progression at enrolment in drug-naïve Parkinson’s disease (PD) subjects over 48 months of follow-up, we describe the annual rate of progression…
  • 2017 International Congress

    Incorporating Specialist Independent Prescribing Pharmacist (SIPP) sessions into the Movement Disorder Service

    D. Fletcher, E. Thomas, B. Mohamed (Cardiff, United Kingdom)

    Objective: To describe the incorporation of a prescribing pharmacist into a Multi-disciplinary Parkinson's clinic based in a University Hospital Background: Evidence shows that a multidisciplinary…
  • 2017 International Congress

    INTREPID Trial: A Prospective, Double blinded, Multi-center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple-Source, Constant-Current Rechargeable System in Parkinson’s Disease

    J. Vitek, R. Jain, P. Starr (Minneapolis, MN, USA)

    Objective: The objective of the INTREPID clinical trial is to assess the improvement in motor function and quality of life in patients with advanced, levodopa-responsive…
  • 2017 International Congress

    Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis

    C. Tarolli, K. Andrzejewski, M. Bull, S. Goldenthal, M. O'Brien, T. Simuni, G. Zimmerman, K. Biglan, E.R. Dorsey (Rochester, NY, USA)

    Objective: To demonstrate the feasibility, reliability, and value of conducting web-based clinical trial assessments in individuals with Parkinson disease (PD). Background: Increasing interest has been…
  • « Previous Page
  • 1
  • …
  • 282
  • 283
  • 284
  • 285
  • 286
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley